Progenics Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report
- Pages: 50
- Published: January 2021
- Report Code: ML2689271SA
Progenics Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Progenics Pharmaceuticals, Inc. (Progenics or 'the company') is a biopharmaceutical company focused on the development of innovative medicines and other technologies for targeting and treating cancer. Its product portfolio includes therapeutic agents such as AZERDA and PSMA TTC that are designed to precisely target cancer and prostate-specific membrane antigen ("PSMA") targeted imaging agents including PyL used to treat prostate cancer. In addition, it also enters into licensing agreements with the University of Zurich and the Paul Scherrer, The University of Western Ontario, Johns Hopkins University and with Bayers subsidiary for acquiring worldwide sublicensable rights to enhance their product candidates. The company is headquartered in New York, the US.
Scope
– Detailed information on Progenics Pharmaceuticals, Inc. required for business and competitor intelligence needs
– A study of the major internal and external factors affecting Progenics Pharmaceuticals, Inc. in the form of a SWOT analysis
– An in-depth view of the business model of Progenics Pharmaceuticals, Inc. including a breakdown and examination of key business segments
– Intelligence on Progenics Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
– News about Progenics Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
– Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of Progenics Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Progenics Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Progenics Pharmaceuticals, Inc.'s business structure, strategy and prospects.
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.